APA (7th ed.) Citation

AJ, L., A, S., TE, V., K, F., SS, H., M, J., . . . AA, K. (2024). Children with non-central nervous system tumors treated with platinum-based chemotherapy are at risk for hearing loss and cognitive impairments. Frontiers in pediatrics, 12, 1341762. https://doi.org/10.3389/fped.2024.1341762

Chicago Style (17th ed.) Citation

AJ, L'Hotta, et al. "Children with Non-central Nervous System Tumors Treated with Platinum-based Chemotherapy Are at Risk for Hearing Loss and Cognitive Impairments." Frontiers in Pediatrics 12 (2024): 1341762. https://doi.org/10.3389/fped.2024.1341762.

MLA (9th ed.) Citation

AJ, L'Hotta, et al. "Children with Non-central Nervous System Tumors Treated with Platinum-based Chemotherapy Are at Risk for Hearing Loss and Cognitive Impairments." Frontiers in Pediatrics, vol. 12, 2024, p. 1341762, https://doi.org/10.3389/fped.2024.1341762.